Evolution and Innovation in Reconstructive Breast Surgery: A Comprehensive Review

This chapter provides a comprehensive overview of contemporary techniques and recent advances in reconstructive breast surgery, integrating evidence-based practices, surgical outcomes, and patient-centered considerations. Both autologous and implant-based reconstruction methods are examined in detail, with emphasis on indications, risks, and comparative outcomes. Particular attention is given to the timing of reconstruction in the setting of postmastectomy radiation therapy (PMRT), the role of acellular dermal matrices (ADMs), and the impact of comorbidities such as diabetes mellitus on complication rates. Recent meta-analyses and multicenter studies indicate that autologous reconstruction—particularly with deep inferior epigastric perforator (DIEP) flaps—offers greater patient satisfaction and lower long-term complication rates compared to implant-based techniques, although with increases operative complexity and donor-site morbidity. Evidence suggests that microvascular breast reconstruction can be safely performed as early as 6 months after the completion of PMRT, without a significant increase in major complications. Furthermore, key predictors of postoperative complications, including obesity, hypertension, and diabetes, are identified to support preoperative risk stratification and optimization. Overall, the chapter underscores the importance of individualized surgical planning, multidisciplinary collaboration, and long-term follow-up in achieving optimal outcomes for patients undergoing breast reconstruction after cancer treatment.